INTRODUCTION
Zinc ethylphenyldithiocarbamate (EPDC) is used widely as an intermediate compound for production of household and industrial articles. In particular, EPDC is a major material for manufacturing rubber goods and is utilized as the most popular vulcanizing accelertor and also as an anti-aging reagent in rubber processing1). As regards the acute toxicity of EPDC, an LD50 value of 553mg/kg was reported in the case of oral administration to rats2).
When EPDC (1mg/kg/day, 6 days a week) was orally administered to rats for 10 months, hematological abnormalities and pathomorophological changes in the internal organs3) were observed. Long-term administration of a rubber extract containing EPDC to rats resulted in growth suppression, decreases in hemoglobin content and red blood cell number, and changes in the weights of the liver and spleen4). The administration of EPDC to pregnant rats led to an increase in the number of dead fetues4). As for the metabolism of EPDC, ethylaniline and aniline were detected as metabolites in blood5). Aniline is known to cause methemoglobinemia6,7).
We previously reported that administration of EPDC (422mg/kg/day) to rats for 2 weeks caused growth suppression, decreases in hemoglobin and red blood cell number, and increases in methemoglobin and the weight of the spleen8).
From these previous findings, it is estimated that the damage to hematopoietic organs is caused by administration of EPDC. Since EPDC is contained in the rubber used for household articles, it may therefore, be necessary to examine the toxic effect on hematopoietic organs. In this study, we investigated the excretion, distribution and metabolism of EPDC, by administrating synthesized 14C-labeled EPDC to rats. The urine sample was diluted with water to a volume of 50ml, and 0.5-1ml of the diluted urine was placed in a vial containing scintillator for radioactivity counting. The feces sample was dried by standing 3-4 days at room temperature, powdered and treated in the same way as organs and tissues with a liquid scintillation counter (LSC-652, Aloka Tokyo, Japan). 3) Expired air: 14C-EPDC was given in a single peroral administration to each of 3 rats. Expired air was collected by promptly placing each rat in an expired-air-collecting apparatus (Sugiyamagen, Tokyo, Japan) having a constant volume (500ml/2hr) of an absorption mixture (ethanolamine: methanol=(8: 2)) to absorb 14C in expired air. One milliliter of this absorption mixture was placed in a vial and added with 10ml of scintillator was added for radioactivity counting. Radioactivity was measured with a liquied scintillation spectrometer (model LSC-652, Aloka, Tokyo, Japan). 4) Blood: Blood was drawn from the vein (vena cava cranilis) into a heparinized syringe under ether anesthesia. After being washed twice with physiological saline, red cells were hemolysed with an equal volume of water, followed by separation of the stroma and endosoma by centrifugation. 5) Non-protein sulfhydryl content in the liver: The rats were fasted for 16 hr before dosing with EPDC, but had free access to water. EPDC dosing solution was administered orally to 6 groups of 5 rats each, and the rats were anaesthetized with ether and sacrificed 0, 1, 3, 6, 15 and 24 hr later. The liver was removed and the non-protein sulfhydryl contents in liver were determined by a modification of the method of Ellmanl10), that is liver homogenates (20%) in 5% trichloroacetic acid containing 1mM Na-EDTA Other substances, all of reagent grade, were purchased from Wako Pure Chemicals Co.. Ltd.
RESULTS AND DISCUSSION 1. Excretion in feces and urine: The percentage excretion of 14C into feces from the 14C-EPDC administered was about 60% in 24 hr and about 65% in 72 hr, while that into urine was about 15% in 24 hr and about 25% in 72 hr (Fig, 1) . Since as much as 60% of the 14C appeared in feces, it appeared taht EPDC was excreted directly in feces without absorption. As 25% of radioactivity was excreted in urine, it was also inferred that 25-40% of administered 14C-EPDC was absorbed via gastro intestinal tract.
2. 14C in the Expired air: Immediately after oral administration of 14C-EPDC, the expired air was collected for 24 hr. The radioactivities contained in the expired air for 0-4 hr, 4-14 hr and 14-24 hr were 3.3%, 1.9% and 0.63% of the dose, respectively.
Thus, a total of 5.83% was excreted in the expired air in 24 hr, and about a half of this 5.83% was excreted within 4 hr. Although finer fractionation of the expired air was not carried out, the peak of 14C expired into the air may be within 4 hr after administra- tion, because the peak of 14C in organs and tissues was observed at 6 hr.
It was estimated from the labeled position in the molecule that the labeled metabolites of EPDC in expired air included 14CO2, 14CS2 and 14COS. However, as it is inconceivable that unchanged 14C-EPDC is excreted in the expired air, 14CS2 is thought to represent the majority of the 14C in the expired air. 3. Distribution:
As shown in Fig. 2 , all organs and tissues examined showed the highest 14C contents 3 -6 hr after the oral administration of 14C-EPDC , and the radioactivity declined with time. In the early stage after the administration, the radio activity (dpm/g) was highest in the blood , followed by the liver and kidney. Although these 14C concentrations decreased with time, the liver and kidney still showed higher levels after 24 hr than other organs and tissues.
Radioactivity
(% of dose) at the peak time in each organ compared to the amount administered was 37% for blood, 5% for liver, and 1% for kidney (Fig. 3) . When the biological half life was estimated from the maximum values and the values at 72 hr shown in Fig. 2 , it was found to be 12 hr for blood, 24 hr for liver and 13 hr for kidney. The biological half life of EPDC in blood was similar to that of kidney, while the half life in liver was about twice as long as that of blood and kidney.
On the other hand, the half-life of glutathione in red blood cells is known to be 2-4 days13). If the half-life of glutathione in the blood after the administration of EPDC is similar to that in red blood cells, the half-life of 14C in blood should be not much longer than that of glutathione.
Therefore, our experiment suggested that the 14C in the red blood cell may be combined not only with glutathione but also with proteins.
Since a considerable amount of radioactivity was present in blood, the distribution of 14C in blood was then studied. Table 1 summarizes the distribution of 14C-EPDC in rat blood. It was found that about 0.91% of the radioactivity in the blood sample was present in the serum, indicating that the majority of the radioactivity was in existence in red blood cells. Separation of the red blood cell revealed that endosoma contained the majority of 14C, while the cells membrane, and that stroma, only had a small amount of 14C in the blood after 24 hrs. Therefore, it is possible to infer that the majority of EPDC molecules or thier metabolites combine with the contents of red blood cells and behave as a causal factor of methemoglobinemia. 4. Non-protein sulfhydryl content in liver: The non-protein sulfhydryl content in the liver was measured to estimate the chemical form of labeled EPDC in the organ (Fig. 4) . The non-protein sulfhydryl level in the liver was found to rapidly decrease from 1 hr to 3 hr after the EPDC administration, and showed the lowest value at 6 hrs.
Later than 6 hr, however, the non-protein sulfuhydryl content increased gradually and was restored to the original level in 15-24 hrs.
Thus, changes of the non-protein sulfuhydryl content in the liver after the EPDC administration were found to be opposite to the change of the 14C level in the liver after the 14C-EPDC administration. These results suggest that EPDC is metabolized in the liver and that its matabolites (i. g., zinc, ethylaniline, carbon disulfide and the reactive metabolite believed to be N-acetylimidoquinon) combine with the SH group of GSH14-17. It has been reported that the reactive metabolite of acetaminophen will covalently bind to protein or react with GSH to form an acetaminophen-GSH conjugate. 5. Metabolites in urine: EPDC was given to rats by a single oral administration, and EPDC metabolites in the urine samples collected 8, 24 and 48 hrs later were examined (Figs. 5 and 6 ).
The TLC of hydrolyzed urine samples showed several spots, and two of these spots had amino groups. These amino group containing spots (Fig.  5) were reexamined by TLC, and acetoamino- Table 1 Distribution of 14C in fractions of rat blood sampled at 24 hours after oral administration of 14C -EPDC . Each point represents the mean of 3 rats.
phenol (Fig. 6, II) , N-ethylaniline and aniline (Fig. 6, I ) were identified by comparison with known compounds.
As shown in Fig. 6 , the ion peaks in MS confirmed this compound as acetoaminophenol.
HPLC of hydrolyzed urine samples demonstrated that N-ethylaniline is a metabolite of EPDC (Fig. 7) . When the level of N-ethylaniline in the urine was measured with time, 1.9%, 17% and 19.5%
(cumulative values, Fig. 8 ) of the administered amount were excreted in 8 hr, 24 hr and 48 hr, respectivly. Thus, about 78% of this 19.5% was excreted in between 8 and 24 hrs after administration.
On the other hand, 12% of 14C due to 14C-EPDC was excreted in urine between 8 and 24 hrs after administration, and 15% of N-ethylaniline was excreted in the same times period. If 14C was due to 14CS2, EPDC should be not excreted unchanged because EPDC was metabolized to CS2, N-ethylaniline, aniline and acetoamino- Fig. 9 Postulated pathway of EPDC metabolism phenol in the rat.
As described above and illustrated in Fig. 9 , N-ethylaniline and aniline were detected in urine as metabolites of EPDC, and acetoaminophenol was also found as a metabolite of aniline. On the basis of these findings, it is inferred that EPDC is metabolized in the rat liver and that zinc is released from EPDC in the stomach (the gastric juice of the rat highly acidic).
N-Ethylaniline and CS2 are produced by breakage of the N-C bond. N-Ethylaniline was further metabolized to aniline by deethylation and the resultant aniline was hydrolyzed to aminophen.ol and further to acetoaminophenol by acethylation of the amino group. N-Ethylaniline has been showen to be a metabolite of EPDC in rat blood by gas chromatography5).
Therefore, it is reasonable, that N-ethylaniline and acetoaminophenol are detected as metabolites of EPDC in urine.
It has also been reported that about 50-80% of 14C-aniline administered to rabbits in a single oral dose is metabolized to p-acetoaminophenol, about 9% is to the o-isomer and about 0.1% is to the misomer, and all these metabolites are excreted as glucronate and sulfate conjugates in urine18-20). In a previous study 50-80% of aniline and acetoaminophenol were found in urine18). The reactive metabolite of acetoaminophen, however, has many characteristics (hepatic necrosis and metohemoglobinemia) attributed to N-acetylimidoquinon ( Fig. 9) 17,20) These results suggest that methemoglobinea induced by administration of EPDC may be due to aminophenol, which is a derivative of the EPDC metabolites, N-ethylaniline and aniline. CS2 is also one of the metabolites of EPDC. As CS2 is also known to have toxicity for the liver21), it is also conceivable that the toxicity of EPDC in the rat is due to the additive or potentiating effects of aniline derivatives and CS2. Taking such a possibility into account, we would like to further investigate further the toxicity of EPDC.
